UnitedHealth Group (NYSE:UNH) Shares Up 1% – Still a Buy?

UnitedHealth Group Incorporated (NYSE:UNH)’s stock price shot up 1% during trading on Tuesday . The company traded as high as $273.38 and last traded at $272.2960. 5,809,206 shares were traded during mid-day trading, a decline of 41% from the average session volume of 9,921,009 shares. The stock had previously closed at $269.54.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Company push into AI and efficiency gains — UNH emphasized expanded AI investments and operational improvements at its recent conference and reiterated its growth/earnings outlook, supporting near-term confidence in margins if initiatives scale as planned. UnitedHealth (UNH) Expands AI Investments to Boost Efficiency
• Positive Sentiment: Market commentary arguing fears are overblown — analysis from market commentators frames recent sell-offs as exaggerated versus UNH’s diversified model and stable cash generation, which can attract long-term investors at lower multiples. UnitedHealth Group: Fears Remain Overblown
• Neutral Sentiment: Wall Street rating overview — Coverage pieces review analyst views and consensus recommendations; this context helps explain volatility when downgrades or target cuts hit but does not itself change fundamentals. Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street’s Bullish Views?
• Neutral Sentiment: Industry comparisons and upside debate — Analysts contrast UNH’s consistency with peers (e.g., Centene), useful for relative-value decisions but not an immediate catalyst. The Upside Debate: UnitedHealth’s Consistency vs. Centene’s Comeback
• Negative Sentiment: DOJ antitrust escalation — The Justice Department has intensified its probe into how Optum interacts with UnitedHealth’s insurance business, raising regulatory and structural-risk concerns that can pressure valuation and deal activity. DOJ Antitrust Probe Puts Focus On UnitedHealth Valuation And Integrated Model
• Negative Sentiment: Analyst downgrades and earnings estimate cuts — Recent coverage highlights downgrades and a pessimistic earnings revision from Zacks, which contribute to the stock’s 2026 weakness and can weigh on sentiment until guidance/earnings prove resilient. UnitedHealth (UNH) Stock Faces Pressure from Analyst Downgrades and Regulatory Challenges
• Negative Sentiment: Financial performance/cost pressure narrative — Coverage noting an expanding gap between reimbursement rates and medical expenses underscores near-term margin risk and helps explain the stock’s pullback year-to-date. UnitedHealth Stock Is Down 18% in 2026 and Keeps Stumbling

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Jefferies Financial Group decreased their price objective on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Truist Financial lowered their price target on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Barclays decreased their price objective on shares of UnitedHealth Group from $391.00 to $327.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Finally, Piper Sandler reissued an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. One analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $372.13.

UnitedHealth Group Trading Up 1.0%

The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.72. The firm has a market cap of $247.16 billion, a P/E ratio of 20.64, a P/E/G ratio of 1.27 and a beta of 0.41. The stock has a 50 day simple moving average of $295.77 and a 200-day simple moving average of $324.10.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company had revenue of $113.73 billion for the quarter, compared to analysts’ expectations of $113.38 billion. During the same quarter in the previous year, the business posted $6.81 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.3% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend was Monday, March 9th. UnitedHealth Group’s payout ratio is presently 67.02%.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Sarver Vrooman Wealth Advisors purchased a new position in UnitedHealth Group in the 4th quarter worth about $25,000. Beacon Financial Strategies CORP bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC increased its holdings in UnitedHealth Group by 220.0% during the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $27,000. Finally, Nalls Sherbakoff Group LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at $27,000. Institutional investors own 87.86% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.